Abstract
Humans have lost their vitamin C-synthesizing capacities during evolution. Therefore, the uptake of this essential compound from external sources is mandatory in order to prevent vitamin C-deficient conditions resulting in severe morbidities such as scurvy. The potent antioxidant, immunomodulatory, and antiinfectious effects of vitamin C are known since the 1930s. We here (i) review the impact of vitamin C on innate and adaptive immune functions, (ii) provide an overview of its antimicrobial, antibacterial, antiviral, antiparasitic, and antifungal properties, and finally, (iii) discuss vitamin C as an adjunct treatment option for the combat of human infections by bacteria, particularly by emerging multidrug-resistant species.
Introduction
In the 1920s, vitamin C was first identified by the prospective Nobel laureate Albert Szent-Györgyi from Szeged University in Hungary, who unraveled the role of this essential vitamin for the treatment and prevention of scurvy resulting from vitamin C deficiency [1–5]. Vitamin C is the generic term for L-threo-hexo-2-enono-1,4-lactone [6], which constitutes a low molecular weight carbohydrate [1, 7]. Chemically, vitamin C is a gluconic acid lactone derived from glucuronic acid and water-soluble ketolactone with 2 ionizable hydroxyl groups with prominent antioxidant properties [1, 6]. In nature, the 2 essential isomeric molecules of vitamin C are found in equal parts, namely the reduced form D-ascorbic acid and the chemically active and oxidized form L-ascorbic acid [8], which are mutually interchangeable [1, 6, 9, 10]. Vitamin C has a strong potential to reduce distinct molecules while being reversibly oxidized to dehydroascorbic acid (DHA), which can be reduced back to vitamin C exhibiting full biological activity [1, 6, 11]. The intracellular transport of vitamin C takes place in every kind of cells as DHA through glucose transporters (GLUT) following a concentration gradient due to the structure similarity to glucose [8, 12] or actively as ascorbic acid via the sodium-dependent vitamin C transporters (SVCT)-1 and -2 [13, 14] in specific organs such as the small intestines, liver, kidneys, adrenal glands, brain, and retina [15]. Inside the cell, DHA is subsequently reduced to ascorbic acid [16]. Due to these characteristics, vitamin C in involved in several vital processes such as energy metabolism and gene transcription, as well as in regulation of hormonal and epigenetic pathways [17].
The natural sources of vitamin C are citrus fruits, kiwi, mango, strawberries, papaya, tomatoes, green leafy vegetables, and broccoli, for instance [1, 7, 10, 18–20]. Interestingly, the vast majority of vertebrates can synthesize vitamin C from glucose, but a few mammals including guinea pigs and humans have lost this ability due to a lack of L-glucono-γ-lactone oxidase, which is necessary for the synthesis of vitamin C in vivo [1, 2, 7, 8, 10, 18, 21, 22]. Therefore, humans need to acquire vitamin C from a diet that supplies 100 to 200 mg of vitamin C per day to cover the general human needs [23, 24] and to decrease the risk of vitamin C-deficient conditions resulting in scurvy, which might be fatal if left untreated [7]. In order to prevent scurvy, a low daily dose of 10 mg is needed [25]. Individuals with scurvy exhibit down-regulated immune responses [26] and are hence highly susceptible towards infections [2, 17]. Given that vitamin C is essentially involved in collagen biosynthesis and repair, the lack of ascorbic acid impairs integrity of basement membranes, mucosal epithelia, and connective tissues, which is causative for the devastating periodontal disease observed in scurvy. Furthermore, the vitamin is required for proper wound healing and bone development, both of which linked to the role of ascorbic acid in collagen synthesis. Other biochemical functions of vitamin C include carnitine synthesis, redox-reactions, production of adrenal steroids and catecholamines, metabolism of amino acids and cholesterol, and iron absorption [5, 27, 28].
Several studies revealed that vitamin C possesses antimicrobial properties, thus reducing the risk of infections, and have immunomodulatory functions, particularly in high concentrations [8]. However, one needs to take into consideration that inappropriate storage, processing and preparation procedures of food might result in vitamin C degradation [7], further supporting the demand of appropriate dietary supplementation of this essential vitamin in order to reduce the risk of deficiency. Furthermore, given that vitamin C is water-soluble, intoxication upon excess intake is virtually impossible since vitamin C in concentrations exceeding the daily demands will be excreted via the kidneys [29]. Given its anti-infectious and immunomodulatory properties on one side and the lack of unwanted side effects on the other, vitamin C constitutes a promising antibiotic-independent strategy to combat and/or prevent bacterial (including enteropathogenic) infections. Therefore, this review will focus on the immunomodulatory and antimicrobial effects of vitamin C.
Immunomodulatory Properties of Vitamin C
A critical basal concentration of vitamin C is essential for a normal and well-functional host defense mechanism, and pharmacological application of vitamin C is believed to enhance immune function [30]. Several studies revealed that experimentally induced vitamin C deficiency reduces cellular [31–33] and humoral immune responses [33, 34]. Furthermore, the effect of vitamin C on different immune cell populations has been shown in both experimental in vivo models and in humans [35–38]. In clinical studies, vitamin C treatment of healthy subjects promoted and enhanced natural killer cell activities, lymphocyte proliferation, and chemotaxis [30, 39]. Furthermore, high doses of vitamin C not only stimulated murine immune cells, primarily dendritic cells, to more distinct interleukin (IL)-12 secretion [40], but also activated T and B cell functions [34, 41].
In addition, the observations that vitamin C concentrations in immune cells such as leukocytes are 10- to 100-fold higher than those measured in the plasma [6] and the fact that these cells accumulate vitamin C against a concentration gradient further underline the immunological importance of vitamin C [42, 43] and support its role as crucial player in various aspects of immune cell functions, such as immune cell proliferation and differentiation [17, 44–46], besides its anti-inflammatory properties [47, 48]. Moreover, the newly characterized hydroxylase enzymes, which regulate the activity of the hypoxia-inducible factors (HIF), gene transcription, and cell signaling of immune cells, require vitamin C as a cofactor for optimal activity [49–52].
In the gastrointestinal tract, vitamin C plays an important role as essential micronutrient and antioxidant protecting intestinal cells from inflammatory stimuli [1, 53]. However, in the inflamed mucosa of patients suffering from chronic inflammatory bowel disease (IBD) such as Crohn's disease and ulcerative colitis [54, 55], the mucosal vitamin C concentrations are highly reduced [56]. Furthermore, when applying vitamin C to duodenal explants derived from patients suffering from coeliac disease due to a hypersensitivity reaction to wheat gliadin and similar proteins from rye and barley [57], a decreased secretion of pro-inflammatory mediators in response to gluten could be assessed [58]. In addition, in a small study cohort, intravenous high dose vitamin C application was found to be beneficial as an adjunct treatment option of colorectal cancer [59]. Hence, vitamin C has been shown to exhibit potent immunomodulatory activity in the course of distinct gastrointestinal inflammatory morbidities. In the following paragraph, we will focus on the effect of vitamin C on distinct immune cell populations.
Monocytes and Macrophages
As pivotal components of the innate immune system, monocytes and macrophages are the first line of defense against invading pathogens [60]. The high vitamin C concentrations measured in monocytes [17, 26, 61] underline the regulatory role of this vitamin in monocyte and macrophage functions. In support, an in vitro study revealed that intracellular accumulation of pharmacologic vitamin C concentrations could effectively inhibit apoptotic pathways in human monocytes [16]. Vitamin C may also regulate distinct genes expressed in human macrophages, which are induced by lipopolysaccharide (LPS) via nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation [62]. Moreover, vitamin C application to monocytes derived from human whole blood diminished secretion of pro-inflammatory cytokines such as IL-6 and tumor necrosis factor (TNF)-α [63]. In addition, vitamin C treatment was shown to stimulate and enhance phagocytosis and clearance of macrophages in vitro [17, 33]. Taken together, these findings underline the important role of vitamin C in host defense against pathogens.
Neutrophils
The exposure of neutrophils to oxidants inhibits their motility, which is related to oxidation of membrane lipids and affecting cell membrane fluidity [17]. As a potent water-soluble antioxidant, vitamin C can neutralize reactive oxidants and also regenerate cellular and membrane antioxidants such as glutathione and vitamin E (tocopherol) [64]. In order to protect themselves from oxidative damage, neutrophils accumulate millimolar (mM) concentrations of vitamin C [65], resulting in improved cellular motility and migration in response of chemotactic stimuli [66] and, subsequently, in enhanced phagocytosis of microbes and generation of reactive oxygen species (ROS) [17].
In support, oral administration of vitamin C has been shown to enhance neutrophilic functions and to result in increased serum immunoglobulin levels in aging patients [67]. Interestingly, neutrophils isolated from sepsis patients exhibited compromised functional capabilities regarding chemotaxis and the generation of ROS [68, 69]. These phenomena might be associated with decreased vitamin C concentrations in the plasma and leukocytes during infectious diseases and stress conditions [6, 33], which is related to the oxidation of ascorbic acid to DHA, the active form of vitamin C [6, 70].
T Lymphocytes
T lymphocytes as key players in acquired (adaptive) immunity are impacted by vitamin C, as shown by both in vitro [40, 41] and in vivo studies [8]. The development and maturation of murine [37, 71] and human [72] T cells are enhanced in the presence of vitamin C in physiological concentrations, whereas proliferation and viability of T lymphocytes are also affected [37]. In a clinical study with elderly patients who received vitamin C (500 mg/day) versus placebo for one month, an increased T cell proliferation could be assessed in the serum as compared to the placebo group [73]. These results are supported by several in vitro studies with human and murine T cells. In human peripheral lymphocytes, vitamin C application promoted T cell proliferation [72, 74]. In another report, however, a decreased number of human IL-2 producing T cells could be assessed in the presence of vitamin C, whereas TNF-α and interferon (IFN)-γ expressing T lymphocytes were not affected [63]. In murine splenic T cell cultures, only high vitamin C levels (0.25–0.5 mM) have been shown to decrease T cell viability and secretion of pro- and anti-inflammatory cytokines such as TNF-α, IFN-γ, and IL-4 by activated T cells, which was not the case following incubation with lower vitamin C concentrations [41]. In support, a recent in vivo study revealed that vitamin C administration during sepsis modified regulatory T cell activity by directly enhancing cell proliferation and by inhibiting the expression of distinct transcription factors, cytokines, and antigens directed against regulatory T cells [75].
Furthermore, T cell activation has been shown to increase expression of SCVT2 [8, 17], which is directly related to a more pronounced cellular uptake of ascorbic acid, further underlining the pivotal role of vitamin C during T cell activation. Given that ROS are formed during T cell activation and act as a second messenger [76–78], it is highly likely that vitamin C affects T cell activation as an antioxidant [8].
B Lymphocytes
B lymphocytes are the main components of adaptive humoral immunity and control the antigen-specific immunoglobulin (Ig) production [37]. Like T cells, B lymphocytes are capable of accumulating vitamin C, whereas in the absence of vitamin C, the viability of B cells derived from murine spleens was shown to be decreased [79], further underlining the essential role of vitamin C in proliferation, viability, and function also of B cells. Interestingly, an in vitro study revealed a slight dose-dependent apoptosis induction in vitamin C-pretreated murine IgM/CD40-activated B cells, whereas lower vitamin C concentrations promoted antioxidant properties in activated B cells and did not affect cell proliferation and expression of distinct surface molecules, such as CD80 and CD86 [34].
Further studies addressed the effect of vitamin C on antibody production by B cells. To investigate if vitamin C might be beneficial for vaccination strategies directed against infectious bursal disease, specific pathogen-free (SPF) chickens received 1 g/mL vitamin C supplementation and showed higher immunoglobulin levels as compared to placebo controls [80, 81]. In support, a clinical trial with healthy male university students revealed that vitamin C supplementation was associated with a significant increase in the serum IgA and IgM concentrations [82]. Thus, these results underline the regulatory effects of vitamin C in B cell proliferation and function.
Natural Killer Cells
Natural killer (NK) cells are arising from the same lymphoid progenitors as T and B lymphocytes [37] and play important roles in the elimination of pathogens including viruses [83]. Proliferation of human NK cells derived from peripheral blood mononuclear cells could be accelerated by co-incubation with vitamin C resulting in higher cell numbers with accurate functional capacity [84]. Furthermore, the cytotoxic capabilities of NK cells could be blocked via platelet aggregation around migrating tumor cells, whereas in vitro vitamin C application increased the cytotoxic activity of NK cells directed against tumor cells [85]. Patients suffering from β-thalassemia major are known to display compromised cytotoxic activity of NK cells [86], which could be rescued by vitamin C application [87]. In healthy subjects, however, the cytotoxic capacities of NK cells could not be further enhanced by vitamin C stimulation [87]. Future in vivo trials need to further unravel the vitamin C related effects on NK cell functions.
Antimicrobial Properties of Vitamin C
As early as the 1930s, vitamin C has been known for its antimicrobial effects directed against Mycobacterium tuberculosis, the infectious agents of human tuberculosis [88–91]. An in vivo study from 1933 revealed that administration of tuberculosis sputum to vitamin C-deficient guinea pigs led to intestinal tuberculosis, whereas the guinea pigs that had received vitamin C-containing tomato juice did not suffer from the disease [92]. Initially it was hypothesized that the antimicrobial properties of vitamin C were due to its pH lowering effect [93]. Another study, however, could prove potent antimicrobial effects of vitamin C directed against group A hemolytic streptococci, even in a nearly pH-neutral environment [94].
Further studies assessed the antibacterial effects of vitamin C against distinct bacterial (opportunistic) pathogens, in more detail, applying microdilution assays. Vitamin C concentrations of 0.31 mg/mL could effectively inhibit Pseudomonas aeruginosa growth in vitro [95]. In addition, vitamin C application at low concentration (0.15 mg/mL) was shown to inhibit the growth of Staphylococcus aureus [95]. Furthermore, vitamin C could even effectively counteract biofilm formation by methicillin-resistant S. aureus (MRSA), displaying low-level resistance to vitamin C (8 to 16 μg/mL) [96]. Interestingly, pH-neutralized vitamin C had only a minor inhibitory effect on S. aureus growth [97]. Furthermore, low concentration of vitamin C (0.15 mg/mL) was shown to have antibacterial effects directed against Enterococcus faecalis [95]. These results are contrasted by another study revealing that the E. faecalis growth was not affected upon co-incubation with 0.22 mg/mL of vitamin C [98]. Thus, the antibacterial effects of vitamin C might be both, bacterial strain and concentration dependent. In support, vitamin C had only a marginal effect on the growth of Escherichia coli ATTC 11775 strain [97]. In combination with lactic acid, however, vitamin C inhibited replication of E. coli O157:H7 strain when incubated in brain heart infusion broth or in carrot juice [99], whereas another study reported that vitamin C even reduced the sensitivity of E. coli MG1655 to streptomycin [100].
Notably, the co-administration of vitamin C could sufficiently enhance the antibacterial effects of other agents such as epigallocatechin gallate directed even against multidrug-resistant bacterial species such as MRSA [101], which also held true for vitamin C in combination with deferoxamine against Gram-positive cocci, such as S. aureus and S. epidermidis, as well as against Gram-negative bacilli, including E. coli, Klebsiella pneumoniae and Proteus mirabilis [102]. Synergistic antibacterial effects could also be observed upon co-administration of vitamin C and quercetin [97], whereas the combination of vitamin C with natural extracts such as pomegranate rind extracts [103] and white tea [104] resulted in enhanced anti-S. aureus properties of the latter.
In the following paragraph, we will focus on the antimicrobial effect of vitamin C on distinct food-borne Gram-negative bacterial pathogens causing frequent human diseases – some leading to prominent morbidity.
Anti-Helicobacter Effects of Vitamin C
In an in vitro study, 10 to 20 mg vitamin C per ml could effectively inhibit Helicobacter pylori growth under microaerobic conditions, whereas in an aerobic milieu, vitamin C even promoted H. pylori survival in concentrations ranging from 2 to 20 mg/mL [105]. These observations might be explained by the antioxidant properties of vitamin C, protecting microaerophilic bacteria against toxic effects of ROS. Following one-week treatment of H. pylori-infected Mongolian gerbils with 10 mg vitamin C daily, gastric pathogen loads could be significantly lowered [106]. In support, several clinical studies reported more effective H. pylori eradication upon vitamin C application to infected humans [107–109]. In addition, oxidative stress, apoptotic responses, and decreased cellular viability that had been induced in an H. pylori-infected human gastric adenocarcinoma cell line could be counteracted by vitamin C application in its L-ascorbic acid-2-glucoside form [110].
Anti-Salmonella Effects of Vitamin C
It was reported that vitamin C did not exhibit significant antibacterial activity against Salmonella enterica in cantaloupe puree [111]. In contrast, vitamin C exhibited antibacterial effects against Salmonella Enteritidis in an in vitro study using a broiler-digestive model including the crop compartment, the proventriculus, and the intestine [112]. Interestingly, in the crop compartment, vitamin C alone could even more effectively inhibit Salmonella growth inhibition, as compared to a combination with curcumin and boric acid, whereas conversely, in the proventriculus and intestine, only the combination of vitamin C, curcumin and boric acid exhibited significant antibacterial activity against S. Enteritidis [112]. Furthermore, a recent study revealed that the antibacterial effect of vitamin C against S. enterica subsp. enterica serovar Typhi and Vibrio fluvialis could be enhanced when applied in a combination with linalool and copper [113]. The effect of this triple combination on bacterial morphology was demonstrated by scanning electron microscopy using V. fluvialis, which showed severe membrane damage, whereas no toxicity could be assessed in human embryonic kidney (HEK293) cells at synergistic concentrations (16.3 μM, 8 mM, and 1.298 mM vitamin C) [113].
Anti-Campylobacter Effects of Vitamin C
Supported by several in vitro studies in the 1980s, vitamin C in a combination with linalool and copper was shown to exhibit synergistic activities against Campylobacter jejuni [113]. Fletcher et al. demonstrated the inhibitory effect of vitamin C (0.5 mg/mL) on C. jejuni growth in vitro, mainly caused by vitamin C oxidation products such as L-dehydroascorbic acid or L-diketogulonic acid [114]. Interestingly, vitamin C in concentrations below 1 mM even stimulated C. jejuni growth, whereas 5 mM of vitamin C killed the bacterial cells [115]. This bactericidal effects of vitamin C was further confirmed on C. jejuni-contaminated turkey meat, given that C. jejuni death rates increased in vitamin C treated samples (5 mmol/kg) [116]. To date studies addressing potential anti-C. jejuni effects of vitamin C in vivo are missing, however.
Anti-Viral, Anti-Parasitic and Anti-Fungal Effects of Vitamin C
The antimicrobial properties of vitamin C are not restricted to bacterial cells. Several studies reported that vitamin C, especially in form of DHA, inhibited the replication of herpes simplex virus type 1, poliovirus type 1 [117], and influenza virus type A [117, 118]. Moreover, vitamin C effectively inactivated the rabies virus in vitro [119]. Also, anti-parasitic effects of vitamin C could be demonstrated. A previous in vivo study revealed reduced parasite counts in Trypanosoma cruzi [120] and Plasmodium yoelii 17XL [22]-infected mice, when treated with vitamin C as compared to placebo control animals, which might also be due to the immunomodulatory properties of vitamin C. In support, another study demonstrated that high doses of vitamin C application (i.e., 8.56 mg/kg body weight) can dampen malarial parasitaemia in infected mice, but surprisingly, the co-administration of vitamin C and the anti-malaria drug artemether [121] reduced parasitic clearance in Plasmodium berghei malaria infected mice as compared to artemether application alone [122]. In addition, anti-fungal effects of vitamin C have also been reported. One study showed vitamin C-associated inhibition of Hsp90-mediated morphogenesis in Candida albicans, whereas in another study, vitamin C exhibited low-level fungistatic activities against C. albicans [95]. Thus, vitamin C possesses potent antimicrobial properties reducing pathogenicity of bacteria, viruses, parasites, and fungi.
Summary and Conclusions
For a few vertebrate species including humans having lost their capacities to synthesize vitamin C themselves during evolution, the uptake of this essential compound from external sources is mandatory in order to prevent from vitamin deficient conditions resulting in severe morbidities such as scurvy. However, vitamin C supplementation is well tolerated and safe, given a virtual absent risk of intoxication upon uncompromised renal function. The biological role of vitamin C is related to its reversibly oxidized form and is involved in a multitude of both enzymatic and non-enzymatic processes. Additionally, vitamin C is a powerful antioxidant compound directed against free radicals and ROS. Leukocytes including lymphocytes can actively accumulate vitamin C against a concentration gradient, which underlines not only vitamin C dependent functional but also developmental immune cell features. In fact, vitamin C has a pivotal impact on both innate and adaptive immune responses. Vitamin C is also involved in bacterial metabolism. It is known that several bacteria can ferment vitamin C, whereas the presence of this vitamin exposes others to oxidative stress, which may result in bacterial growth inhibition. The potent antibacterial effects of vitamin C are, at least in part, due to its low pH and thus milieu-modifying properties. Notably, vitamin C is able to inhibit the growth of S. aureus and streptococci even under neutral pH conditions. Potent growth-inhibitory effects against multi-drug resistant (MDR) bacteria such as MRSA and proven synergistic effects with natural or synthetic antibiotic compounds open novel avenues for the combat of infections with emerging MDR bacterial species. However, both in vitro and in vivo (experimental and clinical) studies are needed to better understand the molecular mechanism of antimicrobial synergies. This applies not only to bacterial, but also to viral, parasitic, and fungal infections.
List of Abbreviations:
| CFU |
colony-forming units |
| DHA |
dehydroascorbic acid |
| GLUT |
glucose transporter |
| HIF |
hypoxia-inducible factors |
| IBD |
inflammatory bowel disease |
| IFN |
interferon |
| Ig |
immunoglobulin |
| IL |
interleukin |
| LPS |
lipopolysaccharide |
| MDR |
multi-drug resistant |
| MRSA |
methicillin-resistant Staphylococcus aureus |
| NF-κB |
nuclear factor kappa-light-chain-enhancer of activated B cells |
| NK cell |
natural killer cell |
| ROS |
reactive oxygen species |
| SPF |
specific pathogen-free |
| SVCT |
sodium-dependent vitamin C transporter |
| TNF |
tumor necrosis factor |
Funding Sources
This work was supported from the German Federal Ministries of Education and Research (BMBF) in the frame of the zoonoses research consortium PAC-Campylobacter to S.M., S.B., and M.M.H. (IP7/ 01KI1725D) and from the German Federal Ministries of Economy and Energy to SB and MMH (ZIM; ZF4117904 AJ8).
Authors' Contributions:
S.M. wrote the paper. S.B. and M.M.H. co-edited paper.
Conflicts of Interest
S.B. and M.M.H. are Editorial Board members.
References
- 1.↑
Sorice A , Guerriero E, Capone F, Colonna G, Castello G, Costantini S. Ascorbic acid: its role in immune system and chronic inflammation diseases. Mini Rev Med Chem. 2014;14(5):444–52.
- 3.
Hemila H . Vitamin C, respiratory infections and the immune system. Trends Immunol. 2003;24(11):579–80.
- 4.
Grzybowski A , Pietrzak K. Albert Szent-Györgyi (1893–1986): The scientist who discovered vitamin C. Clinics in Dermatology. 2013;31(3):327–31.
- 6.↑
Strohle A , Wolters M, Hahn A. Micronutrients at the interface between inflammation and infection–ascorbic acid and calciferol: part 1, general overview with a focus on ascorbic acid. Inflamm Allergy Drug Targets. 2011;10(1):54–63.
- 8.↑
Hong JM , Kim JH, Kang JS, Lee WJ, Hwang YI. Vitamin C is taken up by human T cells via sodium-dependent vitamin C transporter 2 (SVCT2) and exerts inhibitory effects on the activation of these cells in vitro. Anat Cell Biol. 2016;49(2):88–98.
- 9.↑
Traikovich SS . Use of topical ascorbic acid and its effects on photodamaged skin topography. Arch Otolaryngol Head Neck Surg. 1999;125(10):1091–8.
- 11.↑
Bohndiek SE , Kettunen MI, Hu DE, Kennedy BW, Boren J, Gallagher FA, et al. Hyperpolarized [1-13C]-ascorbic and dehydroascorbic acid: vitamin C as a probe for imaging redox status in vivo. J Am Chem Soc. 2011;133(30):11795–801.
- 12.↑
Rumsey SC , Kwon O, Xu GW, Burant CF, Simpson I, Levine M. Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem. 1997;272(30):18982–9.
- 13.↑
Tsukaguchi H , Tokui T, Mackenzie B, Berger UV, Chen XZ, Wang Y, et al. A family of mammalian Na+−dependent L-ascorbic acid transporters. Nature. 1999;399(6731):70–5.
- 14.↑
Rajan DP , Huang W, Dutta B, Devoe LD, Leibach FH, Ganapathy V, et al. Human placental sodium-dependent vitamin C transporter (SVCT2): molecular cloning and transport function. Biochem Biophys Res Commun. 1999;262(3):762–8.
- 15.↑
Savini I , Rossi A, Pierro C, Avigliano L, Catani MV. SVCT1 and SVCT2: key proteins for vitamin C uptake. Amino Acids. 2008;34(3):347–55.
- 16.↑
Perez-Cruz I , Carcamo JM, Golde DW. Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells. Blood. 2003;102(1):336–43.
- 18.↑
Farris PK . Cosmeceutical vitamins: vitamin C. Cosmeceuticals, 3rd ed. Draelos ZD, editor. 2014. p. 37–42.
- 19.
Habermehl G , Hammann P, Krebs HC, Ternes W. Naturstoffchemie: eine einführung. Springer-Verlag; 2008.
- 20.↑
Block G , Norkus E, Hudes M, Mandel S, Helzlsouer K. Which plasma antioxidants are most related to fruit and vegetable consumption? American Journal of Epidemiology. 2001;154(12):1113–8.
- 22.↑
Qin X , Liu J, Du Y, Li Y, Zheng L, Chen G, et al. Different doses of vitamin C supplementation enhances the Th1 immune response to early Plasmodium yoelii 17XL infection in BALB/c mice. Int Immunopharmacol. 2019;70:387–95.
- 23.↑
Levine M , Dhariwal KR, Welch RW, Wang Y, Park JB. Determination of optimal vitamin C requirements in humans. The American journal of clinical nutrition. 1995;62(6 Suppl):1347S–56S.
- 24.↑
Carr AC , Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. The American journal of clinical nutrition. 1999;69(6):1086–107.
- 25.↑
Krebs H. The Sheffield Experiment on the vitamin C requirement of human adults. Proceedings of the Nutrition Society. 1953;12(3):237–46.
- 26.↑
Ang A , Pullar JM, Currie MJ, Vissers MC. Vitamin C and immune cell function in inflammation and cancer. Biochemical Society Transactions. 2018;46(5):1147–59.
- 27.↑
Johnston CS , Beezhold BL, Mostow B, Swan PD. Plasma vitamin C is inversely related to body mass index and waist circumference but not to plasma adiponectin in nonsmoking adults. J Nutr. 2007;137(7):1757–62.
- 28.↑
Johnston CS , Corte C, Swan PD. Marginal vitamin C status is associated with reduced fat oxidation during submaximal exercise in young adults. Nutr Metab (Lond). 2006;3:35.
- 29.↑
Chambial S , Dwivedi S, Shukla KK, John PJ, Sharma P. Vitamin C in disease prevention and cure: an overview. Indian J Clin Biochem. 2013;28(4):314–28.
- 30.↑
Heuser G , Vojdani A. Enhancement of natural killer cell activity and T and B cell function by buffered vitamin C in patients exposed to toxic chemicals: the role of protein kinase-C. Immunopharmacol Immunotoxicol. 1997;19(3):291–312.
- 31.↑
Alvares O , Altman LC, Springmeyer S, Ensign W, Jacobson K. The effect of subclinical ascorbate deficiency on periodontal health in nonhuman primates. J Periodontal Res. 1981;16(6):628–36.
- 32.
Goldschmidt MC , Masin WJ, Brown LR, Wyde PR. The effect of ascorbic acid deficiency on leukocyte phagocytosis and killing of actinomyces viscosus. Int J Vitam Nutr Res. 1988;58(3):326–34.
- 33.↑
Wintergerst ES , Maggini S, Hornig DH. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab. 2006;50(2):85–94.
- 34.↑
Woo A , Kim JH, Jeong YJ, Maeng HG, Lee YT, Kang JS, et al. Vitamin C acts indirectly to modulate isotype switching in mouse B cells. Anat Cell Biol. 2010;43(1):25–35.
- 35.↑
Xi D . Vitamin C in Cancer Therapeutics and Metastasis. Journal of orthopedic research and therapy. 2019;10(1).
- 36.
Sgavioli S , De Almeida VR, Matos Junior JB, Zanirato GL, Borges LL, Boleli IC. In ovo injection of ascorbic acid and higher incubation temperature modulate blood parameters in response to heat exposure in broilers. British poultry science. 2019;60(3):279–87.
- 37.↑
Gorkom GNY , Klein Wolterink RGJ, Van Elssen C, Wieten L, Germeraad WTV, Bos GMJ. Influence of Vitamin C on Lymphocytes: An Overview. Antioxidants (Basel, Switzerland). 2018;7(3).
- 38.↑
Gorkom GNY , Lookermans EL, Van Elssen C, Bos GMJ. The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review. Nutrients. 2019;11(5).
- 39.↑
Levy R , Shriker O, Porath A, Riesenberg K, Schlaeffer F. Vitamin C for the treatment of recurrent furunculosis in patients with imparied neutrophil functions. J Infect Dis. 1996;173(6):1502–5.
- 40.↑
Jeong YJ , Hong SW, Kim JH, Jin DH, Kang JS, Lee WJ, et al. Vitamin C-treated murine bone marrow-derived dendritic cells preferentially drive naive T cells into Th1 cells by increased IL-12 secretions. Cell Immunol. 2011;266(2):192–9.
- 41.↑
Maeng HG , Lim H, Jeong YJ, Woo A, Kang JS, Lee WJ, et al. Vitamin C enters mouse T cells as dehydroascorbic acid in vitro and does not recapitulate in vivo vitamin C effects. Immunobiology. 2009;214(4):311–20.
- 42.↑
Washko P , Rotrosen D, Levine M. Ascorbic acid in human neutrophils. The American journal of clinical nutrition. 1991;54(6 Suppl):1221S–7S.
- 43.↑
Levine M , Wang Y, Padayatty SJ, Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci U S A. 2001;98(17):9842–6.
- 44.↑
Maggini S , Wintergerst ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr. 2007;98 Suppl 1:S29–35.
- 45.
Webb AL , Villamor E. Update: effects of antioxidant and non-antioxidant vitamin supplementation on immune function. Nutr Rev. 2007;65(5):181–217.
- 46.↑
Esteban MA , Wang T, Qin B, Yang J, Qin D, Cai J, et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell. 2010;6(1):71–9.
- 47.↑
Carcamo JM , Borquez-Ojeda O, Golde DW. Vitamin C inhibits granulocyte macrophage-colony-stimulating factor-induced signaling pathways. Blood. 2002;99(9):3205–12.
- 48.↑
Bowie AG , O'Neill LA. Vitamin C inhibits NF-kappa B activation by TNF via the activation of p38 mitogen-activated protein kinase. J Immunol. 2000;165(12):7180–8.
- 49.↑
Kuiper C , Vissers MC. Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression. Front Oncol. 2014;4:359.
- 50.
Loenarz C , Schofield CJ. Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends Biochem Sci. 2011;36(1):7–18.
- 51.
Flashman E , Davies SL, Yeoh KK, Schofield CJ. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents. Biochem J. 2010;427(1):135–42.
- 52.↑
Kuiper C , Dachs GU, Currie MJ, Vissers MC. Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response. Free Radic Biol Med. 2014;69:308–17.
- 53.↑
Aditi A , Graham DY. Vitamin C, gastritis, and gastric disease: a historical review and update. Digestive diseases and sciences. 2012;57(10):2504–15.
- 54.↑
Duchmann R , Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol. 1995;102(3):448–55.
- 55.↑
Ichim TE , Minev B, Braciak T, Luna B, Hunninghake R, Mikirova NA, et al. Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med. 2011;9:25.
- 56.↑
Buffinton GD , Doe WF. Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients. Free radical research. 1995;22(2):131–43.
- 57.↑
Sollid LM . Coeliac disease: dissecting a complex inflammatory disorder. Nature Reviews Immunology. 2002;2(9):647.
- 58.↑
Bernardo D , Martínez-Abad B, Vallejo-Diez S, Montalvillo E, Benito V, Anta B, et al. Ascorbate-dependent decrease of the mucosal immune inflammatory response to gliadin in coeliac disease patients. Allergologia et immunopathologia. 2012;40(1):3–8.
- 59.↑
El Halabi I , Bejjany R, Nasr R, Mukherji D, Temraz S, Nassar FJ, et al. Ascorbic Acid in Colon Cancer: From the Basic to the Clinical Applications. International journal of molecular sciences. 2018;19(9).
- 60.↑
Asmis R. Monocytes and Macrophages: A Fresh Look at Functional and Phenotypic Diversity. Antioxid Redox Signal. 2016;25(14):756–7.
- 61.↑
Levine M , Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A. 1996;93(8):3704–9.
- 62.↑
Parahuleva MS , Jung J, Burgazli M, Erdogan A, Parviz B, Holschermann H. Vitamin C suppresses lipopolysaccharide-induced procoagulant response of human monocyte-derived macrophages. Eur Rev Med Pharmacol Sci. 2016;20(10):2174–82.
- 63.↑
Hartel C , Strunk T, Bucsky P, Schultz C. Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes. Cytokine. 2004;27(4–5):101–6.
- 64.↑
Parker H , Albrett AM, Kettle AJ, Winterbourn CC. Myeloperoxidase associated with neutrophil extracellular traps is active and mediates bacterial killing in the presence of hydrogen peroxide. J Leukoc Biol. 2012;91(3):369–76.
- 65.↑
Washko PW , Wang Y, Levine M. Ascorbic acid recycling in human neutrophils. J Biol Chem. 1993;268(21):15531–5.
- 66.↑
Buettner GR . The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys. 1993;300(2):535–43.
- 67.↑
Jayachandran M , RANI PJA, ARIVAZHAGAN P, PANNEERSELVAM C. Neutrophil phagocytic function and humoral immune response with reference to ascorbate supplementation in aging humans. Journal of Anti-Aging Medicine. 2000;3(1):37–42.
- 68.↑
Arraes SM , Freitas MS, Silva SV, Paula Neto HA, Alves-Filho JC, Auxiliadora Martins M, et al. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. Blood. 2006;108(9):2906–13.
- 69.↑
Demaret J , Venet F, Friggeri A, Cazalis MA, Plassais J, Jallades L, et al. Marked alterations of neutrophil functions during sepsis-induced immunosuppression. J Leukoc Biol. 2015;98(6):1081–90.
- 71.↑
Manning J , Mitchell B, Appadurai DA, Shakya A, Pierce LJ, Wang H, et al. Vitamin C promotes maturation of T-cells. Antioxid Redox Signal. 2013;19(17):2054–67.
- 72.↑
Huijskens MJ , Walczak M, Koller N, Briede JJ, Senden-Gijsbers BL, Schnijderberg MC, et al. Technical advance: ascorbic acid induces development of double-positive T cells from human hematopoietic stem cells in the absence of stromal cells. J Leukoc Biol. 2014;96(6):1165–75.
- 73.↑
Kennes B , Dumont I, Brohee D, Hubert C, Neve P. Effect of vitamin C supplements on cell-mediated immunity in old people. Gerontology. 1983;29(5):305–10.
- 74.↑
Molina N , Morandi AC, Bolin AP, Otton R. Comparative effect of fucoxanthin and vitamin C on oxidative and functional parameters of human lymphocytes. Int Immunopharmacol. 2014;22(1):41–50.
- 75.↑
Gao YL , Lu B, Zhai JH, Liu YC, Qi HX, Yao Y, et al. The Parenteral Vitamin C Improves Sepsis and Sepsis-Induced Multiple Organ Dysfunction Syndrome via Preventing Cellular Immunosuppression. Mediators Inflamm. 2017;2017:4024672.
- 76.↑
Williams MS , Kwon J. T cell receptor stimulation, reactive oxygen species, and cell signaling. Free Radic Biol Med. 2004;37(8):1144–51.
- 77.
Belikov AV , Schraven B, Simeoni L. T cells and reactive oxygen species. J Biomed Sci. 2015;22:85.
- 78.↑
Murphy MP , Siegel RM. Mitochondrial ROS fire up T cell activation. Immunity. 2013;38(2):201–2.
- 79.↑
Ichiyama K , Mitsuzumi H, Zhong M, Tai A, Tsuchioka A, Kawai S, et al. Promotion of IL-4- and IL-5-dependent differentiation of anti-mu-primed B cells by ascorbic acid 2-glucoside. Immunol Lett. 2009;122(2):219–26.
- 80.↑
Wu CC , Dorairajan T, Lin TL. Effect of ascorbic acid supplementation on the immune response of chickens vaccinated and challenged with infectious bursal disease virus. Vet Immunol Immunopathol. 2000;74(1–2):145–52.
- 81.↑
Amakye-Anim J , Lin TL, Hester PY, Thiagarajan D, Watkins BA, Wu CC. Ascorbic acid supplementation improved antibody response to infectious bursal disease vaccination in chickens. Poult Sci. 2000;79(5):680–8.
- 82.↑
Prinz W , Bortz R, Bregin B, Hersch M. The effect of ascorbic acid supplementation on some parameters of the human immunological defence system. Int J Vitam Nutr Res. 1977;47(3):248–57.
- 83.↑
Baggio L , Laureano AM, Silla L, Lee DA. Natural killer cell adoptive immunotherapy: Coming of age. Clin Immunol. 2017;177:3–11.
- 84.↑
Huijskens MJ , Walczak M, Sarkar S, Atrafi F, Senden-Gijsbers BL, Tilanus MG, et al. Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy. Cytotherapy. 2015;17(5):613–20.
- 85.↑
Toliopoulos IK , Simos YV, Daskalou TA, Verginadis II, Evangelou AM, Karkabounas SC. Inhibition of platelet aggregation and immunomodulation of NK lymphocytes by administration of ascorbic acid. Indian J Exp Biol. 2011;49(12):904–8.
- 86.↑
Farmakis D , Giakoumis A, Polymeropoulos E, Aessopos A. Pathogenetic aspects of immune deficiency associated with beta-thalassemia. Med Sci Monit. 2003;9(1):RA19–22.
- 87.↑
Atasever B , Ertan NZ, Erdem-Kuruca S, Karakas Z. In vitro effects of vitamin C and selenium on NK activity of patients with beta-thalassemia major. Pediatr Hematol Oncol. 2006;23(3):187–97.
- 88.↑
Boissevain CH , Spillane Jr JH. A note on the effect of synthetic ascorbic acid (vitamin C) on the growth of the tubercle bacillus. American Review of Tuberculosis. 1937;35(5):661–2.
- 89.
St J L . Der Einfluss von Vitamin C und Vitamin B 1 auf das Wachstum der Tuberkelbacillen. Klinische Wochenschrift. 1937;16(41):1423–5.
- 90.
Sirsi M. Antimicrobial action of vitamin C on M. tuberculosis and some other pathogenic organisms. Indian J Med Sci. 1952;6(252):5.
- 91.↑
Myrvik QN , Volk WA. Comparative study of the antibacterial properties of ascorbic acid and reductogenic compounds. Journal of bacteriology. 1954;68(5):622.
- 92.↑
McConkey M , Smith DT. The relation of vitamin C deficiency to intestinal tuberculosis in the guinea pig. The Journal of experimental medicine. 1933;58(4):503.
- 93.↑
v. Gagyi J. Ueber die bactericide und antitoxische Wirkung des Vitamin C. Journal of Molecular Medicine. 1936;15(6):190–5.
- 94.↑
Slade HD , Knox GA. Nutrition and the role of reducing agents in the formation of streptolysin O by a group A hemolytic streptococcus. Journal of bacteriology. 1950;60(3):301.
- 95.↑
Golonka I , Oleksy M, Junka A, Matera-Witkiewicz A, Bartoszewicz M, Musiał W. Selected Physicochemical and Biological Properties of Ethyl Ascorbic Acid Compared to Ascorbic Acid. Biological and Pharmaceutical Bulletin. 2017;40(8):1199–206.
- 96.↑
Ali Mirani Z , Khan MN, Siddiqui A, Khan F, Aziz M, Naz S, et al. Ascorbic acid augments colony spreading by reducing biofilm formation of methicillin-resistant Staphylococcus aureus. Iranian journal of basic medical sciences. 2018;21(2):175–80.
- 97.↑
Kallio J , Jaakkola M, Mäki M, Kilpeläinen P, Virtanen V. Vitamin C inhibits staphylococcus aureus growth and enhances the inhibitory effect of quercetin on growth of Escherichia coli in vitro. Planta medica. 2012;78(17):1824–30.
- 98.↑
Mehmeti I , Solheim M, Nes IF, Holo H. Enterococcus faecalis grows on ascorbic acid. Appl Environ Microbiol. 2013;79(15):4756–8.
- 99.↑
Tajkarimi M , Ibrahim SA. Antimicrobial activity of ascorbic acid alone or in combination with lactic acid on Escherichia coli O157: H7 in laboratory medium and carrot juice. Food Control. 2011;22(6):801–4.
- 100.↑
Goswami M , Mangoli SH, Jawali N. Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli. Antimicrobial agents and chemotherapy. 2007;51(3):1119–22.
- 101.↑
Hatano T , Tsugawa M, Kusuda M, Taniguchi S, Yoshida T, Shiota S, et al. Enhancement of antibacterial effects of epigallocatechin gallate, using ascorbic acid. Phytochemistry. 2008;69(18):3111–6.
- 102.↑
Van Asbeck B , Marcelis J, Marx J, Struyvenberg A, Van Kats J, Verhoef J. Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid. European journal of clinical microbiology. 1983;2(5):426–31.
- 103.↑
McCarrell EM , Gould SW, Fielder MD, Kelly AF, El Sankary W, Naughton DP. Antimicrobial activities of pomegranate rind extracts: enhancement by addition of metal salts and vitamin C. BMC Complementary and Alternative Medicine. 2008;8(1):64.
- 104.↑
Holloway AC , Gould SW, Fielder MD, Naughton DP, Kelly AF. Enhancement of antimicrobial activities of whole and sub-fractionated white tea by addition of copper (II) sulphate and vitamin C against Staphylococcus aureus; a mechanistic approach. BMC complementary and alternative medicine. 2011;11(1):115.
- 105.↑
Tabak M , Armon R, Rosenblat G, Stermer E, Neeman I. Diverse effects of ascorbic acid and palmitoyl ascorbate on Helicobacter pylori survival and growth. FEMS Microbiol Lett. 2003;224(2):247–53.
- 106.↑
Zhang HM , Wakisaka N, Maeda O, Yamamoto T. Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1997;80(10):1897–903.
- 107.↑
Zojaji H , Talaie R, Mirsattari D, Haghazali M, Molaei M, Mohsenian N, et al. The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation. Digestive and Liver Disease. 2009;41(9):644–7.
- 108.
Sezikli M , Çetinkaya ZA, Sezikli H, Güzelbulut F, Tiftikçi A, Tüzün İnce A, et al. Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C and E increase the eradication rate? Helicobacter. 2009;14(4):280–5.
- 109.↑
Chuang C-H , Sheu B-S, Kao A-W, Cheng H-C, Huang A-H, Yang H-B, et al. Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication. Hepato-gastroenterology. 2007;54(73):320–4.
- 110.↑
Chen X , Liu R, Liu X, Xu C, Wang X. L-ascorbic Acid-2-Glucoside inhibits Helicobacter pylori-induced apoptosis through mitochondrial pathway in Gastric Epithelial cells. Biomed Pharmacother. 2018;97:75–81.
- 111.↑
Mukhopadhyay S , Sokorai K, Ukuku D, Fan X, Juneja V, Sites J, et al. Inactivation of Salmonella enterica and Listeria monocytogenes in cantaloupe puree by high hydrostatic pressure with/without added ascorbic acid. Int J Food Microbiol. 2016;235:77–84.
- 112.↑
Hernandez-Patlan D , Solis-Cruz B, Mendez-Albores A, Latorre JD, Hernandez-Velasco X, Tellez G, et al. Comparison of PrestoBlue((R)) and plating method to evaluate antimicrobial activity of ascorbic acid, boric acid and curcumin in an in vitro gastrointestinal model. J Appl Microbiol. 2018;124(2):423–30.
- 113.↑
Ghosh T , Srivastava SK, Gaurav A, Kumar A, Kumar P, Yadav AS, et al. A Combination of Linalool, Vitamin C, and Copper Synergistically Triggers Reactive Oxygen Species and DNA Damage and Inhibits Salmonella enterica subsp. enterica Serovar Typhi and Vibrio fluvialis. Appl Environ Microbiol. 2019;85(4).
- 114.↑
Fletcher RD , Albers AC, Chen AK, Albertson Jr. JN Ascorbic acid inhibition of Campylobacter jejuni growth. Appl Environ Microbiol. 1983;45(3):792–5.
- 115.↑
Juven BJ , Kanner J. Effect of ascorbic, isoascorbic and dehydroascorbic acids on the growth and survival of Campylobacter jejuni. J Appl Bacteriol. 1986;61(4):339–45.
- 116.↑
Juven BJ , Kanner J, Weisslowicz H, Harel S. Effect of Ascorbic and Isoascorbic acids on Survival of Campylobacter jejuni in Poultry Meat (1). J Food Prot. 1988;51(6):436–7.
- 117.↑
Furuya A , Uozaki M, Yamasaki H, Arakawa T, Arita M, Koyama AH. Antiviral effects of ascorbic and dehydroascorbic acids in vitro. International journal of molecular medicine. 2008;22(4):541–5.
- 118.↑
Kim H , Jang M, Kim Y, Choi J, Jeon J, Kim J, et al. Red ginseng and vitamin C increase immune cell activity and decrease lung inflammation induced by influenza A virus/H1N1 infection. Journal of Pharmacy and Pharmacology. 2016;68(3):406–20.
- 119.↑
Madhusudana SN , Shamsundar R, Seetharaman S. In vitro inactivation of the rabies virus by ascorbic acid. International journal of infectious diseases. 2004;8(1):21–5.
- 120.↑
Puente V , Demaria A, Frank FM, Batlle A, Lombardo ME. Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi. PLoS neglected tropical diseases. 2018;12(9):e0006764.
- 121.↑
Esu E , Effa EE, Opie ON, Uwaoma A, Meremikwu MM. Artemether for severe malaria. The Cochrane database of systematic reviews. 2014(9):Cd010678.
- 122.↑
Ganiyu K , Akinleye M, Tayo F. A Study of the Effect of Ascorbic Acid on the Antiplasmodial Activity of Artemether in Plasmodium Berghei Infected Mice. Journal of Applied Pharmaceutical Science. 2012;2(6):96.